Stocks-OCGN-Ocugen Inc

OCGN Ocugen Inc

1.22 -0.03 (-2.40%)
Market ClosedDelayed Prices By NASDAQ, in USD
Trade
Stocks-OCGN-Ocugen Inc
OCGN Ocugen Inc
Trade

Overview

Prev Close 1.25
Day's Range 1.17 - 1.22
52 Week Range 0.3250 - 2.07
Average Volume (3M) 5.51M
1-Year Return 205.00%
Beta2.3928
Market Cap 359.82M
P/E Ratio-6.78
Revenue3.56M
EPS-0.1843
Dividend (Yield) 0 (0%)
Sector
Health Technology
Industry
Pharmaceuticals Major
CEO
Shankar Musunuri, PhD, MBA
Employees
65

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2023: Ocugen Inc's revenues increased by ∞% and amounted to 6.04M. Net income increased by 22.46% to -63.08M. Net assets decreased by 51.74% to 40.56M and EPS increased from -0.38 to -0.26.
OCGN's Investor Relations
Income StatementBalance SheetCash Flow Statement
Quarterly
Created with Highcharts 4.2.7 /Highstock 4.2.7Total RevenueNet Income09/2312/2303/2406/24-20M-15M-10M-5M05M
Gross Margin
68.77%
Net Profit Margin
-11,147.03%
Operating Margin
-1,532.38%
Return On Investment
-111.85%
09/23
12/23
03/24
06/24
Total Revenue
0
1.41M
1.01M
1.14M
Gross Profit
-177K
1.23M
835K
563K
Operating Income
-15.42M
-11.53M
-12.22M
-15.45M
Net Income
-14.16M
-10.97M
-11.92M
-15.28M